NEW YORK ─ RenalytixAI on Thursday priced its planned initial public offering of 11 million ordinary shares of its stock, saying it anticipates gross proceeds of about $74.3 million.
NEW YORK ─ RenalytixAI on Thursday priced its planned initial public offering of 11 million ordinary shares of its stock, saying it anticipates gross proceeds of about $74.3 million.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.